Live Webinar on "How to Invest successfully to reach goals without losing sleep" Sign up for Live Webinar
investing succesffuly to reach your goals investing succesffuly to reach your goals
X

Colinz Laboratories Ltd Stock Analysis

Small Cap
Evaluated by 122 users | BSE: 531210 | NSE: |
Pharmaceuticals & Drugs
Colinz Laboratories was established in 1987, the company is having modern manufacturing facility near Mumbai. The company is equipped with a full fledged in house testing / quality control laboratory. The company houses well experienced pharmacists / technical personnel in development dept /...

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation
 Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20
Return on Capital Employed 3.04%2.88%2.46%1.02%2.16%2.15%2.95%4%2.59%2.4%
Growth Parameters
Growth Parameters Colour Code Guide
Net Sales (Rs. Cr.) 5.76.67.27.47.98.18.17.97.67.5
Y-o-Y Gr. Rt.-15.8%8.9%2.9%6.6%2.7%-0.6%-1.9%-4.1%-0.5%
Adjusted EPS (Rs.) 0.190.340.190.080.280.270.40.650.340.37
Y-o-Y Gr. Rt.-79%-44.1%-57.9%250%-3.6%48.2%62.5%-47.7%8.8%
Book Value per Share (Rs.) 17.0117.4417.6617.8517.3917.6618.419.0519.3119.29
Adjusted Net Profit 0.10.10.100.10.10.10.20.10.1
Net Op. Cash Flow (Rs. Cr.) 0.80.30.20.60.10.60.10.30.10.6
Debt to Cash Flow from Ops 3.597.8614.952.9424.622.7713.321.255.820.66
Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.
Colinz Laboratories Ltd. should be analysed on a Standalone basis
CAGR
CAGR Colour Code Guide
  9 yrs 5 yrs 3 yrs 1 yr
Net Sales 3.2%-0.9%-2.2%-0.5%
Adjusted EPS 7.7%5.7%-2.6%8.8%
Book Value per Share 1.42.11.6-0.1
Share Price 7.9% 9.2% 28.8% 107.7%
Key Financial Parameter
Performance Ratio Colour Code Guide
 Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20
Return on Equity (%) 1.141.951.110.431.61.522.213.481.791.91
Operating Profit Margin (%) 10.617.767.614.675.765.575.094.544.624.02
Net Profit Margin (%) 1.21.80.960.361.271.171.752.921.611.73
Debt to Equity 0.470.390.360.30.380.260.120.060.10.06
Working Capital Days 263234222220227226226224220198
Cash Conversion Cycle 127108111110114122136137145143
Entity Percentage Holding
Promoters 36.42%
Institutions 0.07%
Non-Institutions 63.51%
Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)
Data is not available for this company.

The 5-year analysis of Colinz Laboratories Ltd's performance infers:

Colinz Laboratories Ltd earnings have grown by 5.7%, whereas share price has appreciated 9.2% CAGR over the past five years, indicating the company's share price is likely overvalued. However, for specific investment actions please connect with your investment advisor.

We analysed the performance of Colinz Laboratories Ltd share prices over the last 10 years. Here is what we found out:

Colinz Laboratories Ltd share price has appreciated 6.5% annually over the past ten years.

Colinz Laboratories was established in 1987, the company is having modern manufacturing facility near Mumbai. The company is equipped with a full fledged in house testing / quality control laboratory.

The company houses well experienced pharmacists / technical personnel in development dept / manufacturing and caters to an ethical promotion of specialty products in India.

The company is having a well experienced marketing team of over 300 personnels and is having expertise in turn

Colinz Laboratories was established in 1987, the company is having modern manufacturing facility near Mumbai. The company is equipped with a full fledged in house testing / quality control laboratory.

The company houses well experienced pharmacists / technical personnel in development dept / manufacturing and caters to an ethical promotion of specialty products in India.

The company is having a well experienced marketing team of over 300 personnels and is having expertise in turn key projects (Design, erection & commissioning of pharma formulation plants) Transfer of technical know how (Pilot Batch to Commercial productions).

Business area of the company spreads to:

Pharmaceutical Formulations (of all dosages forms)

  • Tablets
  • Capsules
  • Parenterals
  • Creams/ Ointments/Lotions
  • Dry Powder
  • Liquid Orals
  • Soft Gelatine Capsules

Therapeutic Segments

  • Anti Biotics & Anti Bacterials
  • Anti Hypertensives
  • Diuretics
  • Lipid lowering Agents (Cholestrole Reducers)
  • Anti Emetics etc.

Vetinary formulations

  • Feed mix
  • Bolus
  • Vitamins & Others

Nutraceuticals

  • Spirulina
  • Co enzyme Q10 
  • Clucosamine
  • Lecithin
  • Vitamins

Herbal Preparations

  • Pain Balm (Instant relief for all types of pain)
  • Anti Cold Rub 

Ayurvedic Skin Care Creams Treatment of

  • Pimples 
  • Fairness
  • Stretch Marks 
  • Cracks

Capsules/Tablets/ Creams/ Powders

  • Anti Piles
  • Laxatives
  • Anti Diabetic
  • Anti Hypertensive
  • Antacid
  • Vigour & Vitality
  • General Debility 

Contract Manufacturing & Technical Know How Product Development

- Product Development & Clinical Research - Technical know how for formulations  - Currently Manufacturing for Europeon & Japanese companies

Sourcing API& / Intermediates Turn key products 

Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback